{"SPADE_UN_11417": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11417", "Peptide Name": "A12L/A20L (V13KL peptide derivative)", "Source": "Synthetic construct", "Family": "Derived from the framework peptide V13KL", "Gene": "Not found", "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS", "Sequence Length": 26, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram-"], "Target Organism": "[Ref.17158938]Gram-negative bacteria:Pseudomonas aeruginosa PAO1(MIC=62.5 μg/ml), Pseudomonas aeruginosa WR5 (MIC=125 μg/ml), Pseudomonas aeruginosa PAK (MIC=62.5 μg/ml), Pseudomonas aeruginosa PA14 (MIC=125 μg/ml), Pseudomonas aeruginosa M2 (MIC=62.5 μg/ml), Pseudomonas aeruginosa CP204 (MIC=62.5 μg/ml), The geometric mean of MIC values above six Gram-negative strains (MIC=78.7 μg/ml).[Ref.22837667]Cancer cell:HeLa cell (IC50=1.71±0.07 μmol/L).", "Hemolytic Activity": "[Ref.22837667]MHC=8.0 μg/ml, MHC=5.20±0.02 μmol/L against human red blood cells", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C145H242N36O34", "Mass": 3033.69, "PI": 10.78, "Net Charge": 8, "Hydrophobicity": -0.06, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-negative bacteria. A12L/A20L against HeLa cells. Leucine to replace Alanine at the position 12 and 20 on the peptide V13KL. Has hemolytic activity.", "Literature": [{"Title": "Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides.", "Pubmed ID": "17158938", "Reference": "Antimicrob Agents Chemother. 2007 Apr;51(4)1398-406.", "Author": "Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17158938"}, {"Title": "Role of helicity on the anticancer mechanism of action of cationic-helical peptides.", "Pubmed ID": "22837667", "Reference": "Int J Mol Sci. 2012;13(6)6849-62. doi 10.3390/ijms13066849.", "Author": "Huang YB, He LY, Jiang HY, Chen YX.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22837667"}], "Frequent Amino Acids": "KLS", "Absent Amino Acids": "CDEGMNOPQRUY", "Basic Residues": 8, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 17, "Positive Residues": 8, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06336", "Similarity": 1.0, "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS"}, {"SPADE_ID": "SPADE_N_06337", "Similarity": 1.0, "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS"}, {"SPADE_ID": "SPADE_UN_11417", "Similarity": 1.0, "Sequence": "KWKSFLKTFKSLKKTVLHTLLKAISS"}]}}}